Skip to main content
Premium Trial:

Request an Annual Quote

Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities

NEW YORK – Schott Minifab, a subsidiary of Schott focused on microfluidics for point-of-care and life sciences consumables, announced on Tuesday that it is acquiring Applied Microarrays.

Financial and other terms of the deal were not disclosed. It is expected to close in early October.

The acquisition will expand Schott Minifab's biosensor printing capabilities and "further strengthen Schott Minifab's ability to offer a single-source contract manufacturing solution," the company said in a statement.

Applied Microarrays, or AMI, will move from Tempe, Arizona, to a larger location in Phoenix, which will increase Australia-based Schott Minifab's manufacturing footprint in the US.

Greg Wolters, head of Schott Minifab, said in a statement that AMI will help the company enhance its capabilities in surface modification, functionalization, and deposition for its glass and polymer products. Schott acquired Minifab, a provider of customized polymer microfluidics, in 2019.

The companies have previously worked together to develop biotech substrates for diagnostics applications. AMI served as parent company Schott's North American distributor starting in 2013.

AMI designs, optimizes, and manufactures DNA and protein biosensors and other microarrays on glass, plastic, and semiconductors. It acquired GE Healthcare's microarray business in 2007.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.